The key vendors mentioned are Biogen, Boehringer Ingelheim, MediciNova, Inc., Afferent Pharmaceuticals, Baxter, Bristol-Myers Squibb, F. Hoffmann-La Roche, Promedior, Merck, Prometic Life Sciences, Galapagos, Cipla Inc., Asahi Kasei Corporation, and Sanofi SA.

Hyderabad, India - October 9, 2019 /MarketersMedia/ —

The Idiopathic Pulmonary Fibrosis market is expected to reach $5,733.24 million by 2026 growing at a CAGR of 13.5% from 2018 to 2026. Idiopathic pulmonary fibrosis is a type of interstitial lung disease in which scarring and thickening of the lung tissue occur due to unknown causes. In turn, this fibrosis reduces the ability of alveoli to transport oxygen from the lungs to the bloodstream and results in symptoms such as dyspnea, chronic dry cough, fatigue, and weight loss. Factors such as the rise in geriatric population, a surge in cigarette smoking population and an increase in a number of patients suffering from idiopathic pulmonary fibrosis are fuelling the market growth. However, unavailability of proper treatment options is restricting the market growth.

Access the complete report at: https://www.syngeneresearch.com/global-idiopathic-pulmonary-fibrosis-market-analysis-2019-2/

Based on the route of administration, the parenteral route segment is to be the most preferred route of drug administration during the forecast period. Drugs administered by the parenteral route bypass the first-pass metabolism and enter the bloodstream directly. This helps in the fast delivery of drugs or nutrients into the body.

Make an inquiry at: https://www.syngeneresearch.com/global-idiopathic-pulmonary-fibrosis-market-analysis-2019-2/

Types Covered:
• Antifibrotic Agents
• Systemic Corticosteroids
• Immunosuppressant Drugs
• Tyrosine Kinase Inhibitors

Drugs Types Covered:
• Nintedanib
• Pirfenidone

Route of Administrations Covered:
• Parenteral
• Oral

Applications Covered:
• Malaria
• Arrhythmias
• Other Applications

End Users Covered:
• Clinics
• Academic and Research Organizations
• Hospitals
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Learn more about Syngeneresearch here: https://www.syngeneresearch.com/about-syngene-research/

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Contact Info:
Name: Sadhana Shukla
Email: Send Email
Organization: Syngene Market Research Reports
Website: https://www.syngeneresearch.com/

Source URL: https://marketersmedia.com/the-global-idiopathic-pulmonary-fibrosis-market-is-expected-to-grow-at-a-cagr-of-135-from-2018-to-2026/88926729

Source: MarketersMedia

Release ID: 88926729